These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 7284201)

  • 1. [Comparison of the effectiveness of amiodarone and quinidine in the prevention of arrhythmia].
    Vitolo E; Tronci M; Larovere MT; Rumolo R
    Boll Soc Ital Cardiol; 1980; 25(9):1101-2. PubMed ID: 7284201
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison between the efficacy of amiodarone and quinidine in the treatment of atrial cardiac arrhythmias.
    Tonet JL; Bernardeau C; Lechat P; Frank R; Touzet I; Fontaine G; Grosgogeat Y
    Br J Clin Pract Suppl; 1986 Apr; 44():42-8. PubMed ID: 3089261
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of atrial fibrillation of recent onset by a combination of quinidine and amiodarone].
    Allaria B; Romanò M; Zucco F; De Gasperi A
    Clin Ter; 1982 Mar; 100(5):477-84. PubMed ID: 7140165
    [No Abstract]   [Full Text] [Related]  

  • 4. Amiodarone versus quinidine in the prophylaxis of atrial fibrillation.
    Vitolo E; Tronci M; Larovere MT; Rumolo R; Morabito A
    Acta Cardiol; 1981; 36(6):431-44. PubMed ID: 7039195
    [No Abstract]   [Full Text] [Related]  

  • 5. [Maintaining sinus rhythm with quinidine and amiodarone after electric cardioversion].
    Aros F; Valles V; Alegria E; Loma-Osorio A; Malpartida F
    Rev Esp Cardiol; 1978; 31(1 Pt 2):185-91. PubMed ID: 663366
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cordarone in the maintenance of sinus rhythm: prevention of paroxysmal atrial fibrillation and of supraventricular paroxysmal tachycardia].
    Zagatti G; Benzoni A; Caturelli G
    Arch Maragliano Patol Clin; 1974; 30(2):245-9. PubMed ID: 4480711
    [No Abstract]   [Full Text] [Related]  

  • 7. [Conversion of recent atrial fibrillation to sinus rhythm. Predictive value of the clinical and echocardiographic parameters].
    Di Michele R; Bertoni PD; Tosetto C
    Boll Soc Ital Cardiol; 1981; 26(10):1305-11. PubMed ID: 7349158
    [No Abstract]   [Full Text] [Related]  

  • 8. [Influence of treatment with amiodarone in response to electric cardioversion in patients with complete arrhythmia caused by auricular fibrillation].
    del Río Ligorit A; Casasnovas Lenguas JA; González Carretero M; Lozano HC; Ferreira Montero IJ
    Med Clin (Barc); 1983 Nov; 81(14):618-20. PubMed ID: 6656399
    [No Abstract]   [Full Text] [Related]  

  • 9. Amiodarone and the cardiomyopathies.
    McKenna WJ
    Br J Clin Pract Suppl; 1986 Apr; 44():3-10. PubMed ID: 3089258
    [No Abstract]   [Full Text] [Related]  

  • 10. Amiodarone--application and clinical pharmacology in atrial fibrillation and other arrhythmias.
    Anastasiou-Nana M; Levis GM; Moulopoulos SD
    Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):229-35. PubMed ID: 6746145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of amiodarone in the treatment of persistent and paroxysmal atrial fibrillation resistant to quinidine therapy.
    Horowitz LN; Spielman SR; Greenspan AM; Mintz GS; Morganroth J; Brown R; Brady PM; Kay HR
    J Am Coll Cardiol; 1985 Dec; 6(6):1402-7. PubMed ID: 4067122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiarrhythmic prophylaxis vs warfarin anticoagulation to prevent thromboembolic events among patients with atrial fibrillation. A decision analysis.
    Middlekauff HR; Stevenson WG; Gornbein JA
    Arch Intern Med; 1995 May; 155(9):913-20. PubMed ID: 7726699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Electric cardioversion in the postoperative period after mitral valve surgery].
    Cañas M; Rosselot I; Bahamonde L; Rosselot E
    Rev Med Chil; 1986 Jul; 114(7):632-5. PubMed ID: 3602705
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention of atrial fibrillation with moderate doses of amiodarone in the postoperative period of cardiac surgery is safe and effective in patients with high risk for developing this arrhythmia.
    Alves RJ; Geovanini GR; Brito Gd; Miguel GA; Glauser VA; Nakiri K
    Arq Bras Cardiol; 2007 Jul; 89(1):22-7. PubMed ID: 17768579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-arrhythmic properties of amiodarone. Clinical experience].
    Iannetti M; Pastorini C; Masperone MA; Caponnetto S
    Arch Maragliano Patol Clin; 1974; 30(2):251-5. PubMed ID: 4480712
    [No Abstract]   [Full Text] [Related]  

  • 16. [Intravenous amiodarone for control of supraventricular tachycardias in cardiac surgery].
    Solares G; Ramos F; Riancho G; Díaz-Terán C; Martín-Durán R; Buitrago M
    Rev Esp Anestesiol Reanim; 1986; 33(3):162-6. PubMed ID: 3738087
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effectiveness of amiodarone in the treatment of arrhythmia].
    Cieśliński A; Jasiński K
    Kardiol Pol; 1981; 24(7):493-500. PubMed ID: 7277941
    [No Abstract]   [Full Text] [Related]  

  • 18. [Amiodarone: pharmacology, clinical use and side effects].
    Popiliev I
    Vutr Boles; 1985; 24(5):17-25. PubMed ID: 3911581
    [No Abstract]   [Full Text] [Related]  

  • 19. The efficacy of intravenous amiodarone for the conversion of chronic atrial fibrillation. Amiodarone vs quinidine for conversion of atrial fibrillation.
    Kerin NZ; Faitel K; Naini M
    Arch Intern Med; 1996 Jan; 156(1):49-53. PubMed ID: 8526696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic therapy of tachyarrhythmias in patients with Wolff-Parkinson-White syndrome.
    Prystowsky EN
    Herz; 1983 Jun; 8(3):133-43. PubMed ID: 6135656
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.